A world-first clinical trial has shown young people with type 1 diabetes have better glycaemic control and quality of life while on hybrid closed loop (HCL) systems versus conventional treatments, Australian endocrinologists say. The randomised trial compared HCL’s six-month glycaemic and psychosocial efficacy with continuous subcutaneous insulin infusion and multiple daily insulin injections with or ...
Type 1 diabetes
Aussies publish first RCT of hybrid closed loop systems in young T1D patients
By Natasha Doyle
12 Oct 2021